A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant

This publication has 20 references indexed in Scilit:

• GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 2002
• Chemotherapy and granulocyte colony stimulating factor‐mobilized blood cell infusion followed by interferon‐α for relapsed malignancy after allogeneic bone marrow transplantation
  Internal Medicine Journal, 2001
• Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial
  The Lancet, 2000
• Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome
  Bone Marrow Transplantation, 1999
• Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation
  Bone Marrow Transplantation, 1999
• Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes
  Bone Marrow Transplantation, 1997
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
  Journal of Clinical Oncology, 1997
• Donor leucocyte infusions for relapse in chronic myelogenous leukaemia
  The Lancet, 1994
• Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A REPORT BY THE EBMT LEUKAEMIA WORKING PARTY
  British Journal of Haematology, 1991
• Acute and chronic graft-versus-host disease in man
  The International Journal of Cell Cloning, 1986